Importantly, this mechanism exerts anti-tumor effects through dual pathways, directly inducing programmed cell death in tumor cells and promoting CD8+ T cell infiltration into the tumor microenvironment by activating the p38/MAPK signaling pathway (29). Here, CD8A is linked to neoplasm.